What is the difference between essential and benign hypertension?
A: When essential hypertension remains in its early stages for a prolonged period of time and without a specific known cause, it is known as benign essential hypertension. In this state, the condition will generally be symptomless and develop very slowly.
What are the current JNC guidelines for hypertension?
In the general population, pharmacologic treatment should be initiated when blood pressure is 150/90 mm Hg or higher in adults 60 years and older, or 140/90 mm Hg or higher in adults younger than 60 years.
What are the BP categories according to JNC 7 and 8?
JNC 8 update on JNC 7 Classification of Blood Pressure
|Normal||< 120||< 80|
|Stage 1 Hypertension||140-159||90-99|
|Stage 2 Hypertension||>160||>100|
What are the JNC 8 guidelines for the management of hypertension?
JNC 8 Guidelines for the Management of Hypertension in Adults Key Points for Practice In the general population, pharmacologic treatment should be initiated when blood pressure is 150/90 mm Hg or higher in adults 60 years and older, or 140/90 mm Hg or higher in adults younger than 60 years.
What are the JNC 8 recommendations for the treatment of hyperkalemia?
No hyperkalemia JNC 8? Hypothetical JNC 8 Recommendations Goal BP likely to be refined (relaxed) for population subgroups, particularly for those >80 and those with DM. Chlorthalidone recommended over HCTZ, but pre-eminence as first line therapy might be challenged.
What does JNC 8 stand for?
The Eighth Joint National Committee (JNC 8) recently released evidence-based recommendations on treatment thresholds, goals, and medications in the management of hypertension in adults. Advertisement AAFPAAFP AAFP FoundationFoundation AFP JournalAFP FPM JournalFPM FMXFMX My AccountCart AFP Journal Issues Current Issue Past Issues 2021 2020 2019
What is the difference between JNC 8 and other societies?
• While JNC 8 has the same treatment recommendations for people with or without diabetes, most other societies suggest that only ACEIs or ARBs should be first-line treatment for patients with diabetes 6 December 2016 Kovell LC et al. J Am Heart Assoc. 2015;4(12): e002315 James PA et al. JAMA. 2014;311:507–20 Title AHA Hypertension Presentation